Works about ALPHA-synuclein
Results: 1419
Recovery of Impaired Mitochondrial Dynamics and Quality Control Mechanisms in Parkinson’s Disease.
- Published in:
- Impulse (19343361), 2024, v. 21, n. 1, p. 1
- By:
- Publication type:
- Article
Polymeric Nanozyme with SOD Activity Capable of Inhibiting Self‐ and Metal‐Induced α‐Synuclein Aggregation.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 37, p. 1, doi. 10.1002/chem.202401331
- By:
- Publication type:
- Article
Insight into the Effect of Methylglyoxal on the Conformation, Function, and Aggregation Propensity of α‐Synuclein.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 36, p. 1, doi. 10.1002/chem.202400890
- By:
- Publication type:
- Article
Development of Pyridothiophene Compounds for PET Imaging of α‐Synuclein.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 23, p. 1, doi. 10.1002/chem.202303921
- By:
- Publication type:
- Article
Probing Peptidylprolyl Bond cis/trans Status Using Distal <sup>19</sup>F NMR Reporters.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 16, p. 1, doi. 10.1002/chem.202203017
- By:
- Publication type:
- Article
A Hydroxylamine‐Mediated Amidination of Lysine Residues That Retains the Protein's Positive Charge.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 31, p. 1, doi. 10.1002/ange.202402880
- By:
- Publication type:
- Article
Taylor Dispersion‐Induced Phase Separation for the Efficient Characterisation of Protein Condensate Formation.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 25, p. 1, doi. 10.1002/ange.202404018
- By:
- Publication type:
- Article
Single‐Molecule Two‐Color Coincidence Detection of Unlabeled alpha‐Synuclein Aggregates.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 15, p. 1, doi. 10.1002/ange.202216771
- By:
- Publication type:
- Article
Decreased Water Mobility Contributes To Increased α‐Synuclein Aggregation**.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 7, p. 1, doi. 10.1002/ange.202212063
- By:
- Publication type:
- Article
α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 1, p. 1, doi. 10.1002/ange.202215360
- By:
- Publication type:
- Article
Direct Observation of "Elongated" Conformational States in α‐Synuclein upon Liquid‐Liquid Phase Separation.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 46, p. 1, doi. 10.1002/ange.202205726
- By:
- Publication type:
- Article
Tailoring a Nanochaperone to Regulate α‐Synuclein Assembly.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 19, p. 1, doi. 10.1002/ange.202200192
- By:
- Publication type:
- Article
Raman optical activity of human α-synuclein in intrinsically disordered, micelle-bound α-helical, molten globule and oligomeric β-sheet state.
- Published in:
- Journal of Raman Spectroscopy, 2017, v. 48, n. 7, p. 910, doi. 10.1002/jrs.5149
- By:
- Publication type:
- Article
Amyloids on Membrane Interfaces: Implications for Neurodegeneration.
- Published in:
- Journal of Membrane Biology, 2022, v. 255, n. 6, p. 705, doi. 10.1007/s00232-022-00245-x
- By:
- Publication type:
- Article
Complex modulation of cytokine-induced α-synuclein aggregation by glypican-1-derived heparan sulfate in neural cells.
- Published in:
- Glycobiology, 2022, v. 32, n. 4, p. 333, doi. 10.1093/glycob/cwab126
- By:
- Publication type:
- Article
In silico Pharmacological Evaluation of Tetrahydro-β-carboline Derivatives as Putative Inhibitors of Alpha-Synuclein and Dopa Decarboxylase for Parkinson’s Disease.
- Published in:
- Trends in Sciences, 2023, v. 20, n. 11, p. 1, doi. 10.48048/tis.2023.6008
- By:
- Publication type:
- Article
Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Rapid restructurization of conformationally-distinct alpha-synuclein amyloid fibrils at an elevated temperature.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.14137
- By:
- Publication type:
- Article
Interplay between epigallocatechin-3-gallate and ionic strength during amyloid aggregation.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.12381
- By:
- Publication type:
- Article
Genetic inactivation of alpha-synuclein affects embryonic development of dopaminergic neurons of the substantia nigra, but not the ventral tegmental area, in mouse brain.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.4779
- By:
- Publication type:
- Article
Genetic inactivation of alpha-synuclein affects embryonic development of dopaminergic neurons of the substantia nigra, but not the ventral tegmental area, in mouse brain.
- Published in:
- PeerJ, 2018, v. 6, p. 1, doi. 10.7717/peerj.4779
- By:
- Publication type:
- Article
Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 2, p. 573, doi. 10.1007/s10072-022-06440-x
- By:
- Publication type:
- Article
Real-time quaking-induced conversion assay is accurate for Lewy body diseases: a meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association between alpha-synuclein (SNCA) rs11931074 variability and susceptibility to Parkinson's disease: an updated meta-analysis of 41,811 patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma alpha-synuclein levels in patients with Parkinson's disease: a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
- Published in:
- 2017
- By:
- Publication type:
- journal article
精神分裂症患者血清 琢-synuclein、MT 水平与睡眠质量、 昼夜节律偏好以及认知功能损害的关系研究.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 12, p. 2382, doi. 10.13241/j.cnki.pmb.2023.12.034
- By:
- Publication type:
- Article
Combined Mesenchymal Stem Cell-Derived Exosomes and H2S Ameliorated the Neurodegenerative Changes in Parkinson's Disease: Implication of PI3K/AKT Signaling Pathway.
- Published in:
- Egyptian Academic Journal of Biological Sciences, C Physiology & Molecular Biology, 2022, v. 14, n. 2, p. 203, doi. 10.21608/EAJBSC.2022.266863
- By:
- Publication type:
- Article
Plasminogen degrades α-synuclein, Tau and TDP-43 and decreases dopaminergic neurodegeneration in mouse models of Parkinson's disease.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59090-8
- By:
- Publication type:
- Article
The Impact of Probiotics on Clinical Symptoms and Peripheral Cytokines Levels in Parkinson's Disease: Preliminary In Vivo Data.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 11, p. 1147, doi. 10.3390/brainsci14111147
- By:
- Publication type:
- Article
Is Hearing Loss a Risk Factor for Idiopathic Parkinson's Disease? An English Longitudinal Study of Ageing Analysis.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 8, p. 1196, doi. 10.3390/brainsci13081196
- By:
- Publication type:
- Article
Histone Deacetylase 4 Inhibition Reduces Rotenone-Induced Alpha-Synuclein Accumulation via Autophagy in SH-SY5Y Cells.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 4, p. 670, doi. 10.3390/brainsci13040670
- By:
- Publication type:
- Article
α-Synuclein and Mechanisms of Epigenetic Regulation.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 1, p. 150, doi. 10.3390/brainsci13010150
- By:
- Publication type:
- Article
Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson's Disease.
- Published in:
- Brain Sciences (2076-3425), 2019, v. 9, n. 4, p. 73, doi. 10.3390/brainsci9040073
- By:
- Publication type:
- Article
Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease.
- Published in:
- Brain Sciences (2076-3425), 2018, v. 8, n. 4, p. 52, doi. 10.3390/brainsci8040052
- By:
- Publication type:
- Article
A Structural Proteomics Exploration of Synphilin-1 and Alpha-Synuclein Interaction in Pathogenesis of Parkinson's Disease.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 12, p. 1588, doi. 10.3390/biom14121588
- By:
- Publication type:
- Article
Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 627, doi. 10.3390/biom14060627
- By:
- Publication type:
- Article
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 1, p. 73, doi. 10.3390/biom14010073
- By:
- Publication type:
- Article
The Effects of Lipids on α-Synuclein Aggregation In Vitro.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1476, doi. 10.3390/biom13101476
- By:
- Publication type:
- Article
Autophagy in Parkinson's Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1435, doi. 10.3390/biom13101435
- By:
- Publication type:
- Article
The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1303, doi. 10.3390/biom13091303
- By:
- Publication type:
- Article
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 8, p. 1263, doi. 10.3390/biom13081263
- By:
- Publication type:
- Article
Disease-Specific α-Synuclein Seeding in Lewy Body Disease and Multiple System Atrophy Are Preserved in Formaldehyde-Fixed Paraffin-Embedded Human Brain.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 936, doi. 10.3390/biom13060936
- By:
- Publication type:
- Article
Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson's Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 865, doi. 10.3390/biom13050865
- By:
- Publication type:
- Article
Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 726, doi. 10.3390/biom13050726
- By:
- Publication type:
- Article
The α-Synuclein Monomer May Have Different Misfolding Mechanisms in the Induction of α-Synuclein Fibrils with Different Polymorphs.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 4, p. 682, doi. 10.3390/biom13040682
- By:
- Publication type:
- Article
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 4, p. 644, doi. 10.3390/biom13040644
- By:
- Publication type:
- Article
Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 287, doi. 10.3390/biom13020287
- By:
- Publication type:
- Article
Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 269, doi. 10.3390/biom13020269
- By:
- Publication type:
- Article
The Role of Membrane Affinity and Binding Modes in Alpha-Synuclein Regulation of Vesicle Release and Trafficking.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 12, p. 1816, doi. 10.3390/biom12121816
- By:
- Publication type:
- Article